Vertex Pharmaceuticals Incorporated Revenue and Competitors
Estimated Revenue & Valuation
- Vertex Pharmaceuticals Incorporated's estimated annual revenue is currently $7.1B per year.
- Vertex Pharmaceuticals Incorporated's estimated revenue per employee is $1,081,450
- Vertex Pharmaceuticals Incorporated's total funding is $656.2M.
- Vertex Pharmaceuticals Incorporated's current valuation is $59.5B. (January 2022)
Employee Data
- Vertex Pharmaceuticals Incorporated has 6593 Employees.
- Vertex Pharmaceuticals Incorporated grew their employee count by 6% last year.
Vertex Pharmaceuticals Incorporated's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff to the Chief Operating Officer | Reveal Email/Phone |
2 | CEO and President | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Executive Director, Accounting | Reveal Email/Phone |
5 | Chief Staff to Head Cell and Gene Therapy Research | Reveal Email/Phone |
6 | Chief Staff, International Business | Reveal Email/Phone |
7 | VP | Reveal Email/Phone |
8 | VP | Reveal Email/Phone |
9 | Regional VP Northern Europe and Australia | Reveal Email/Phone |
10 | EVP, Chief Cell and Genetic Therapies and VCGT Site Head | Reveal Email/Phone |
Vertex Pharmaceuticals Incorporated Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Vertex Pharmaceuticals Incorporated?
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.\n\nWe discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. \n\nFounded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.\n\nVertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
keywords:N/A
$656.2M
Total Funding
6593
Number of Employees
$7.1B
Revenue (est)
6%
Employee Growth %
$59.5B
Valuation
N/A
Accelerator
Vertex Pharmaceuticals Incorporated News
... Eli Lilly, Vertex Pharmaceuticals and Deciphera Pharmaceuticals ... Johnson & Johnson is usually the first pharma company to report...
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers ... In her first full year at the top of cystic fibrosis juggernaut...
The search for an alternative to opioid drugs for pain relief has dragged one for decades, with little success, but Vertex Pharma thinks...
THIRD-QUARTER 2021 FINANCIAL RESULTS NOVEMBER 2, 2021 ©2021 Vertex Pharmaceuticals Incorporated AGENDA Introduction Michael Partridge, Senior Vice President, Investor Relations CEO Perspective and Pipeline Update Reshma Kewalramani, M.D., CEO and President Commercial Update Stuart Arbuc ...
“The program is so needed and timely and we are honored that Vertex, a global biotechnology company, as well as independent organizations and individuals all recognize this urgent need in our community," said Claire’s Place Foundation Executive Director Melissa Yeager. LOS ANGELES (PRWEB) Decem ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1293M | 6597 | N/A | N/A |
#2 | $2729.5M | 7706 | 7% | N/A |
#3 | $1124.3M | 8031 | 8% | N/A |
#4 | N/A | 8189 | 5% | N/A |
#5 | N/A | 8303 | 56% | N/A |